112 related articles for article (PubMed ID: 12457002)
1. Clinical equivalence trial on budesonide delivered either by the Novolizer multidose dry powder inhaler or the Turbuhaler in asthmatic patients.
Chuchalin AG; Kremer HJ; Metzenauer P; O'Keefe E; Hermann R
Respiration; 2002; 69(6):502-8. PubMed ID: 12457002
[TBL] [Abstract][Full Text] [Related]
2. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
3. Novolizer: a multidose dry powder inhaler.
Fenton C; Keating GM; Plosker GL
Drugs; 2003; 63(22):2437-45; discussion 2447-8. PubMed ID: 14609355
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC.
Vastagh E; Kuna P; Calistruc P; Bogdan MA;
Respir Med; 2003 Nov; 97 Suppl D():S20-8. PubMed ID: 14753248
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
Kunkel G; Chuchalin AG
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
[TBL] [Abstract][Full Text] [Related]
6. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
Shapiro GG; Mendelson LM; Pearlman DS
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
[TBL] [Abstract][Full Text] [Related]
7. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
8. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
Banov CH; Howland WC; Lumry WR
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
[TBL] [Abstract][Full Text] [Related]
10. Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma.
Kemp J; Wanderer AA; Ramsdell J; Southern DL; Weiss S; Aaronson D; Grossman J
Ann Allergy Asthma Immunol; 1999 May; 82(5):463-71. PubMed ID: 10353578
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two budesonide powder inhalers, Easyhaler and Turbuhaler, in steroid-naïve asthmatic patients.
Schweisfurth H; Malinen A; Koskela T; Toivanen P; Ranki-Pesonen M;
Respir Med; 2002 Aug; 96(8):599-606. PubMed ID: 12195841
[TBL] [Abstract][Full Text] [Related]
12. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
13. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
Ige OM; Sogaolu OM
Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
[TBL] [Abstract][Full Text] [Related]
14. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler.
Möller M; Fritsche D; Rivera D; Libertus H
Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246
[TBL] [Abstract][Full Text] [Related]
15. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
Morice A; Das S; Ellis S;
J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma.
Otto-Knapp R; Conrad F; Hösch S; Metzenauer P; Maus J; Noga O; Petzold U; Kunkel G
Pulm Pharmacol Ther; 2008; 21(1):47-53. PubMed ID: 17475527
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
20. Deposition and pharmacokinetics of budesonide from the Miat Monodose inhaler, a simple dry powder device.
Ball DJ; Hirst PH; Newman SP; Sonet B; Streel B; Vanderbist F
Int J Pharm; 2002 Oct; 245(1-2):123-32. PubMed ID: 12270249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
